期刊
NEUROCHEMICAL RESEARCH
卷 37, 期 4, 页码 795-801出版社
SPRINGER/PLENUM PUBLISHERS
DOI: 10.1007/s11064-011-0674-0
关键词
Alzheimer's; Serum amyloid P; Beta amyloid plaque; Neurofibrillary tangle; Hippocampus
资金
- NHLBI NIH HHS [R01 HL083029-05, R01 HL083029] Funding Source: Medline
The neuropathological signs of Alzheimer's disease (AD) include beta amyloid plaques and neurofibrillary tangles. There is a significant population of individuals that have these key hallmarks but show no signs of cognitive impairment, termed non-demented with AD neuropathology (NDAN). The protective mechanism allowing these individuals to escape dementia is unknown. Serum amyloid P (SAP) is a serum protein associated with wound repair that is elevated in the brains of Alzheimer's patients and binds to amyloid plaques. Using immunoblotting and immunohistochemistry, we evaluated SAP levels in postmortem samples of hippocampus and frontal cortex in age-matched controls, AD, and NDAN individuals. AD individuals had significantly increased SAP levels compared to normal controls, while NDAN samples had no significant difference in SAP levels compared to normal controls. Our results suggest that low levels of SAP in plaques marks the brains of individuals that escape dementia despite the presence of beta amyloid plaques and tangles.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据